Home›Companies›Autism Diagnostic Technologies

Autism Diagnostic Technologies, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 15, 2023·Suggest an edit

About Autism Diagnostic Technologies

Autism Diagnostic Technologies is a private company based in Bedminster, New Jersey. It has reported $170,000 raised in two offerings on Form D since March 2019. Its chief executive is Andrew Stewart.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 23, 2023Sep 15, 2023$150,000of $600K target9$16,667Equity, Debt, OptionsRule 506(b)Form D ↗
Feb 19, 2019Mar 4, 2019$20,000of $3.0M target1$20,000Equity, OptionsRule 506(c)Form D ↗
Total, two offerings$170,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Autism Diagnostic Technologies's Form D filed Sep 15, 2023.

JK
Joerg Klaube
Executive officer
AS
Andrew Stewart
CEO and Director

Earlier filings also listed Jason Pottinger (director, last listed Mar 2019) and Boura Ali (director, last listed Mar 2019).

Sources

  1. SECAutism Diagnostic Technologies, Inc. filing history